Financial Instruments (Tables)

6 Months Ended

Jul. 03, 2021

Notes To Financial Statements [Abstract]

Schedule of Derivative Instruments in Statement of Financial Position, Fair Value

The following table summarizes the company’s fair value of interest rate swaps (in thousands):

	Condensed Consolidated Balance Sheet Presentation	Jul 3, 2021		Jan 2, 2021
Fair value	Other assets	$	1,188	$	—
Fair value	Accrued expenses	$	9,823	$	14,075
Fair value	Other non-current liabilities	$	24,771	$	37,018

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance

The impact on earnings from interest rate swaps was as follows (in thousands):

		Three Months Ended				Six Months Ended
	Presentation of Gain/(loss)	Jul 3, 2021		Jun 27, 2020		Jul 3, 2021		Jun 27, 2020
Gain/(loss) recognized in accumulated other comprehensive income	Other comprehensive income	$	(4,259)	$	(7,619)	$	7,457	$	(43,404)
Gain/(loss) reclassified from accumulated other comprehensive income (effective portion)	Interest expense	$	(5,207)	$	(3,994)	$	(10,230)	$	(5,261)